NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 156 filers reported holding NEVRO CORP in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $223 | -8.6% | 6,158 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $244 | -99.9% | 6,158 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $287,000 | +6.3% | 6,158 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $270,000 | -39.3% | 6,158 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $445,000 | -10.8% | 6,158 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $499,000 | -30.4% | 6,158 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $717,000 | -29.8% | 6,158 | 0.0% | 0.00% | -20.0% |
Q2 2021 | $1,021,000 | +25.0% | 6,158 | +5.1% | 0.01% | 0.0% |
Q1 2021 | $817,000 | -37.5% | 5,858 | -22.5% | 0.01% | -37.5% |
Q4 2020 | $1,308,000 | +24.2% | 7,558 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $1,053,000 | -7.3% | 7,558 | -20.6% | 0.01% | +60.0% |
Q2 2020 | $1,136,000 | – | 9,516 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 622,615 | $38,920,000 | 8.04% |
Tamarack Advisers, LP | 160,000 | $10,002,000 | 3.97% |
Birch Run Capital Advisors, LP | 187,425 | $11,716,000 | 3.72% |
Prosight Management, LP | 128,765 | $8,049,000 | 3.52% |
Ratan Capital Management LP | 38,653 | $2,416,000 | 3.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,463 | $36,222,000 | 1.39% |
Spark Investment Management LLC | 403,400 | $25,216,000 | 1.17% |
Sivik Global Healthcare LLC | 50,000 | $3,126,000 | 1.15% |
ArrowMark Colorado Holdings LLC | 1,882,009 | $117,644,000 | 1.11% |
PFM Health Sciences, LP | 721,229 | $45,084,000 | 1.00% |